DUBLIN--(BUSINESS WIRE)--The "Global Diabetes Management Devices Market 2017-2021" report has been added to Research and Markets' offering.
The global diabetes management devices market is expected to grow at a CAGR of 8.08% during the period 2017-2021.
The report, Global Diabetes Management Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is the growing focus on artificial pancreas. Diabetes is a serious condition that develops due to the absence of insulin, which is secreted by islets of Langerhans in the pancreas. The artificial pancreas is the newest technology that helps people to manage diabetes automatically by controlling their blood glucose levels by providing the substitute endocrine functionality of healthy pancreas. The launch of the first artificial pancreas by Medtronic has been one of the most revolutionary advances in medical device history. It is a clinically efficient, next-generation insulin pump technology with continuous monitoring of glucose. It has fewer complications and offers greater ability to live without complications.
According to the report, one of the major drivers for this market is the rising global burden of diabetes. Diabetes is a chronic disease, which occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin. Hyperglycemia or increased blood sugar can result in severe damage or complication, which may become life-threatening to the individual if left untreated.
Key vendors
- Abbott
- Dexcom
- F. Hoffmann-La Roche
- LifeScan
- Medtronic
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Market Segmentation By Product
Part 07: Market Segmentation By End-Users
Part 08: Regional Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/wj368w/global_diabetes
